- Home
- BBIO vs DLB Comparison
BBIO vs DLB Comparison
Compare BBIO & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- DLB
- Stock Information
- Founded
- BBIO 2015
- DLB 1965
- Country
- BBIO United States
- DLB United States
- Employees
- BBIO N/A
- DLB N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- DLB Multi-Sector Companies
- Sector
- BBIO Health Care
- DLB Miscellaneous
- Exchange
- BBIO Nasdaq
- DLB Nasdaq
- Market Cap
- BBIO 6.7B
- DLB 7.9B
- IPO Year
- BBIO 2019
- DLB 2005
- Fundamental
- Price
- BBIO $34.57
- DLB $80.31
- Analyst Decision
- BBIO Strong Buy
- DLB Strong Buy
- Analyst Count
- BBIO 12
- DLB 4
- Target Price
- BBIO $52.64
- DLB $99.50
- AVG Volume (30 Days)
- BBIO 2.7M
- DLB 511.5K
- Earning Date
- BBIO 05-01-2025
- DLB 05-01-2025
- Dividend Yield
- BBIO N/A
- DLB 1.64%
- EPS Growth
- BBIO N/A
- DLB 40.49
- EPS
- BBIO N/A
- DLB 2.70
- Revenue
- BBIO $221,902,000.00
- DLB $1,315,146,000.00
- Revenue This Year
- BBIO $12.42
- DLB $7.56
- Revenue Next Year
- BBIO $123.19
- DLB $5.47
- P/E Ratio
- BBIO N/A
- DLB $29.75
- Revenue Growth
- BBIO 2285.27
- DLB 2.71
- 52 Week Low
- BBIO $21.62
- DLB $66.35
- 52 Week High
- BBIO $39.47
- DLB $89.66
- Technical
- Relative Strength Index (RSI)
- BBIO 51.35
- DLB 42.94
- Support Level
- BBIO $35.77
- DLB $81.14
- Resistance Level
- BBIO $37.06
- DLB $82.63
- Average True Range (ATR)
- BBIO 1.40
- DLB 1.45
- MACD
- BBIO 0.18
- DLB -0.16
- Stochastic Oscillator
- BBIO 47.67
- DLB 34.74
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.